Appili Therapeutics, Inc. (APLIF)
0.0055
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
Appili Therapeutics Shareholders Equity (Quarterly) : -13.41M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -13.41M |
| March 31, 2026 | -12.42M |
| December 31, 2025 | -11.95M |
| September 30, 2025 | -11.22M |
| June 30, 2025 | -10.72M |
| March 31, 2025 | -9.309M |
| December 31, 2024 | -9.475M |
| September 30, 2024 | -9.708M |
| June 30, 2024 | -9.052M |
| March 31, 2024 | -8.073M |
| December 31, 2023 | -7.456M |
| September 30, 2023 | -7.172M |
| June 30, 2023 | -6.625M |
| March 31, 2023 | -5.466M |
| December 31, 2022 | -3.953M |
| September 30, 2022 | -2.221M |
| June 30, 2022 | -1.229M |
| Date | Value |
|---|---|
| March 31, 2022 | -2.618M |
| December 31, 2021 | -0.3437M |
| September 30, 2021 | -3.288M |
| June 30, 2021 | 4.734M |
| March 31, 2021 | 10.15M |
| December 31, 2020 | 13.63M |
| September 30, 2020 | 15.75M |
| June 30, 2020 | 16.84M |
| March 31, 2020 | 6.214M |
| December 31, 2019 | 0.5634M |
| September 30, 2019 | 1.395M |
| June 30, 2019 | 2.202M |
| March 31, 2019 | 3.308M |
| December 31, 2018 | 1.876M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | 3.775M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 1.075M |
| NervGen Pharma Corp. | 12.18M |
| Milestone Pharmaceuticals, Inc. | 18.22M |
| Clearmind Medicine, Inc. | 12.95M |
| Lexaria Bioscience Corp. | 4.738M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.9129M |
| Total Liabilities (Quarterly) | 14.32M |
| Debt to Equity Ratio | -0.7005 |
| Current Ratio | 0.0653 |
| Net Debt Paydown Yield | -11.67% |